ORKA
Oruka Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.54 / 10
Outperform
Money flow analysis registers 7.79/10, indicating robust fund inflows across most categories (block, small, medium, extra-large) with only Large flows slightly negative. Analyst sentiment is overwhelmingly bullish, with 66.7% Strong Buy and 33.3% Buy ratings, and historical win rates near 100%. This positive conviction, combined with favorable fund flows, reinforces the technical upswing.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-12
InstitutionBTIG
Times predicted4
Historical Win Rate100.0%
Is money flowing into or out of ORKA?
- ORKA holds a Bullish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.54/10 (Outperform).
